Today: 7 February 2026
Subscribe
Browse Category

Stock Market News 12 November 2025

The Honest Company (HNST) — Today’s News (Nov. 12, 2025): Shares Rebound From 52‑Week Low as Analysts Scrutinize Earnings Quality and ‘Transformation 2.0’

The Honest Company (HNST) — Today’s News (Nov. 12, 2025): Shares Rebound From 52‑Week Low as Analysts Scrutinize Earnings Quality and ‘Transformation 2.0’

Shares of The Honest Company, Inc. (NASDAQ: HNST) bounced off last week’s lows on Wednesday as fresh commentary dissected the company’s cash‑flow quality and near‑term strategy following last week’s Q3 print and the launch of its “Transformation 2.0: Powering Honest Growth” plan. Intraday, the stock traded higher after approaching a new 52‑week trough in recent sessions. Markets Mojo+2 Today’s HNST headlines (November 12, 2025) Context: what changed last week—and why it still matters today Honest’s Q3 2025 report (Nov. 5) mixed a small profit with a softer top line and a strategic pivot: Those details frame today’s discussion: the quality
12 November 2025
Baytex Energy (BTE.TO) Sells Eagle Ford Assets for US$2.305 Billion; Stock Jumps After CIRO Halt — Nov. 12, 2025

Baytex Energy (BTE.TO) Sells Eagle Ford Assets for US$2.305 Billion; Stock Jumps After CIRO Halt — Nov. 12, 2025

Calgary producer exits the U.S., refocuses on higher‑return Canadian oil plays, plans debt repayment and accelerated shareholder returns. Baytex exits the U.S. with a US$2.305B sale Baytex Energy Corp. (TSX: BTE; NYSE: BTE) said today it has signed a definitive agreement to sell all of its U.S. Eagle Ford assets to an undisclosed buyer for US$2.305 billion (about C$3.25 billion) in cash. Management framed the deal as a pivot to “a focused, high‑return Canadian energy producer,” emphasizing heavy oil, Viking light oil, and the rapidly scaling Pembina Duvernay. baytexenergy.com Use of proceeds and capital returns. Baytex intends to repay outstanding
12 November 2025
···
Leap Therapeutics (LPTX) Rebrands as “Cypherpunk,” Buys $50M in Zcash; Ticker to Change to CYPH on Nov. 13 — Q3 Results and New $200M ATM Filed (Nov. 12, 2025)

Leap Therapeutics (LPTX) Rebrands as “Cypherpunk,” Buys $50M in Zcash; Ticker to Change to CYPH on Nov. 13 — Q3 Results and New $200M ATM Filed (Nov. 12, 2025)

Leap Therapeutics, Inc. (Nasdaq: LPTX) unveiled a sweeping strategic pivot today: the oncology company is rebranding as Cypherpunk Technologies Inc., has already purchased ~$50 million of Zcash (ZEC) for a new digital‑asset treasury strategy, and will switch its Nasdaq ticker from LPTX to CYPH at the open on Thursday, Nov. 13, 2025. The company also filed fresh SEC documents, including Q3 2025 results and a $200 million at‑the‑market (ATM) equity program with Cantor Fitzgerald. PR Newswire+2SEC+2 What changed — and why it matters Rebrand & crypto‑treasury pivot. In a 7:00 a.m. ET release, the company said it will adopt the
12 November 2025
·
BILL Holdings (BILL) Surges as Company Explores a Sale — What Investors Need to Know Today (Nov. 12, 2025)

BILL Holdings (BILL) Surges as Company Explores a Sale — What Investors Need to Know Today (Nov. 12, 2025)

BILL Holdings, Inc. (NYSE: BILL) rallied today after multiple outlets reported the SMB payments platform is weighing strategic options, including a potential sale. Below is a concise rundown of what changed today, why it matters, and what to watch next. What happened today Reports of a strategic review lit a fire under BILL’s stock. Reuters said BILL concluded its shares are undervalued and is exploring a sale; talks remain preliminary with no assurance of a transaction. Bloomberg’s legal desk added that a financial adviser is soliciting interest from larger industry rivals and PE sponsors. The company hasn’t commented on the
12 November 2025
·
FMFC Stock Jumps on Nov. 12: Kandal M Venture (NASDAQ: FMFC) Rebounds Pre‑Market After Steep Slide—No New Filings or Fresh Company News

FMFC Stock Jumps on Nov. 12: Kandal M Venture (NASDAQ: FMFC) Rebounds Pre‑Market After Steep Slide—No New Filings or Fresh Company News

Shares of Kandal M Venture Limited (NASDAQ: FMFC)—the Cambodia‑based contract manufacturer of affordable‑luxury leather goods—rallied sharply in Wednesday’s pre‑market session before opening to volatile trading. Early headlines showed FMFC up between ~38% and ~70% pre‑market (readings varied by timestamp and venue), a bounce following a brutal October–November slide. By mid‑session, shares remained higher on heavy volume, with no new corporate filings or press releases to explain the move. chartmill.com+1 What moved today (Nov. 12, 2025) Context: How we got here What the company does Kandal M Venture Limited manufactures handbags and other small leather goods for global brands, with operations
12 November 2025
··
Dollar General (DG) News Today — Nov. 12, 2025: Upstate NY walkout, shopper‑trend headwinds, and where the stock trades now

Dollar General (DG) News Today — Nov. 12, 2025: Upstate NY walkout, shopper‑trend headwinds, and where the stock trades now

Dollar General Corporation (NYSE: DG) makes headlines today as an Upstate New York store team stages a walkout, new shopper data flags softer visits among Hispanic consumers to dollar stores, and investors eye the December 4 earnings date. Below is today’s comprehensive roundup, built for Google News and Discover. Key takeaways (Nov. 12, 2025) 1) Labor & store operations: Duanesburg/Esperance team stages walkout The Times Union reports six employees at Dollar General Store #16215 in Duanesburg (near Esperance), New York, walked out together last Thursday, citing understaffing, a “skeleton crew” schedule, and disappearing sick‑time balances. The piece—updated this morning—notes the
12 November 2025
Clearwater Analytics (CWAN) Weighs Sale; Shares Jump as Wellington Files 6.2% Stake and New Report Flags $2.7T Insurance ‘Alts’ Shift

Clearwater Analytics (CWAN) Weighs Sale; Shares Jump as Wellington Files 6.2% Stake and New Report Flags $2.7T Insurance ‘Alts’ Shift

Clearwater Analytics Holdings, Inc. (NYSE: CWAN) is in the spotlight today after Bloomberg reported the investment‑software company is considering a potential sale following inbound takeover interest. The headline sent CWAN shares higher in Wednesday trading, coinciding with a new industry study the company released on insurers’ growing allocations to alternative assets and a fresh Schedule 13G filing showing Wellington Management as a ≥5% shareholder. SEC+3Bloomberg Law+3 Key takeaways (Nov. 12, 2025) What happened Sale interest surfaces. Bloomberg reported overnight that Clearwater Analytics “is considering a potential sale after receiving takeover interest,” citing people familiar with the matter. Such reports frequently
12 November 2025
··
Viking Holdings (VIK) pops onto Bank of America’s ‘beyond‑AI’ stock list as Q3 results near — Nov. 12, 2025

Viking Holdings (VIK) pops onto Bank of America’s ‘beyond‑AI’ stock list as Q3 results near — Nov. 12, 2025

On Wednesday, Bank of America highlighted Viking Holdings among 16 diversified “hot stock picks” outside the AI trade, citing the company’s dominant share in river cruising and differentiated, culture‑forward itineraries. The nod lands a week before Viking’s third‑quarter results and conference call. MarketWatch+1 What’s new today (Nov. 12, 2025) Key dates & how to listen By the numbers: what the Street is watching Why BofA’s call matters to VIK stock today BofA’s screen is designed to surface buy‑rated names with positive estimate revisions and undemanding valuations outside of AI‑centric tech. For Viking specifically, the thesis leans on category leadership in
12 November 2025
·
CMCT Sells Lending Arm to Peachtree Affiliate for ~$44M; Stock Jumps, CFO Transition Set — Nov. 12, 2025

CMCT Sells Lending Arm to Peachtree Affiliate for ~$44M; Stock Jumps, CFO Transition Set — Nov. 12, 2025

Creative Media & Community Trust Corporation (NASDAQ: CMCT) said it has signed a definitive agreement to sell its lending division to PG FR Holding, LLC, an affiliate of Atlanta-based Peachtree Group. The deal is expected to generate approximately $31 million in net cash for CMCT at closing and advances the company’s pivot toward multifamily growth and balance-sheet strength. Business Wire+1 Deal details: exiting SBA lender PMC/First Western CMCT is divesting First Western SBLC, Inc. (operating as PMC Commercial Trust), a national direct lender focused on SBA 7(a) loans. Peachtree said the acquisition expands its credit platform and noted PMC’s Preferred
12 November 2025
···
Fiserv (FISV, formerly FI) Today: Susquehanna Cuts Price Target to $99; KBW Payments Conference at 12:25 p.m. ET — November 12, 2025

Fiserv (FISV, formerly FI) Today: Susquehanna Cuts Price Target to $99; KBW Payments Conference at 12:25 p.m. ET — November 12, 2025

What happened today Susquehanna trims target to $99, still Positive Susquehanna’s James Friedman reduced his Fiserv target to $99 (from $220), citing adjustments for transitory growth drivers (Argentina inflation effects, Clover-related fee dynamics, license revenue, etc.). Despite the reset, the firm reiterates a Positive stance based on the durability of Clover and the breadth of Fiserv’s installed base. Investing.com+1 KBW Fintech Payments Conference (12:25 p.m. ET) Fiserv confirmed that Mike Lyons (CEO) and Paul Todd (CFO) will participate in a fireside chat at 12:25 p.m. ET today. The company is streaming the session live and archiving a replay on its
12 November 2025
BigBear.ai (BBAI) Today: Stock Moves, $250M Ask Sage Deal, and Q3 Beat — What Investors Need to Know (Nov 12, 2025)

BigBear.ai (BBAI) Today: Stock Moves, $250M Ask Sage Deal, and Q3 Beat — What Investors Need to Know (Nov 12, 2025)

BigBear.ai (NYSE:BBAI) moves on Q3 results and a $250M Ask Sage acquisition. Here’s what changed today, Nov 12, 2025, and what to watch next. Why BBAI is moving today Pre‑market activity. BigBear.ai was one of Nasdaq’s most‑active tickers this morning, changing hands heavily around $6.40 pre‑market, a continuation of Tuesday’s post‑earnings surge. Intraday levels are volatile, as shown above. Nasdaq Fresh analyst signals. A TipRanks AI-generated note this morning cut the price target to $5.50 and set a Neutral stance, citing mixed fundamentals despite the strategic logic of the Ask Sage deal. At the same time, aggregated Street views still
12 November 2025
··
Jumia (JMIA) Q3 2025: Revenue +25%, GMV +21%, Orders Surge; FY‑2025 Loss Guided to $50–55M, Q4’26 Breakeven Target

Jumia (JMIA) Q3 2025: Revenue +25%, GMV +21%, Orders Surge; FY‑2025 Loss Guided to $50–55M, Q4’26 Breakeven Target

Jumia Technologies AG (NYSE: JMIA) reported third‑quarter 2025 results before the U.S. market open today, showing accelerating top‑line growth and improving operating metrics while refining its 2025 loss outlook and reiterating a path to profitability. The Africa‑focused ecommerce group also confirmed tomorrow’s Investor Day and an earnings call at 8:30 a.m. ET today. SEC+1 Key numbers (Q3 2025, year over year) Usage momentum (physical goods, perimeter‑adjusted): Context on mix: As part of its shift away from low‑value digital orders, JumiaPay app orders fell sharply year over year, a deliberate pivot that lifted physical‑goods engagement metrics. SEC Guidance & profitability roadmap
12 November 2025
·
Lucyd (NASDAQ: LUCY) Pops Pre‑Market as Q3 Results Are Expected Today — Rebrand, Exec Moves, and New AI Safety Glasses in Focus (Nov. 12, 2025)

Lucyd (NASDAQ: LUCY) Pops Pre‑Market as Q3 Results Are Expected Today — Rebrand, Exec Moves, and New AI Safety Glasses in Focus (Nov. 12, 2025)

Quick take: Lucyd, Inc. (formerly Innovative Eyewear) is trading sharply higher in Wednesday’s pre‑market ahead of an expected third‑quarter earnings release. Momentum follows an October corporate name change, November executive moves, and last week’s launch of new ANSI‑rated, ChatGPT‑enabled Lucyd Armor® smart‑safety glasses. PR Newswire+3TipRanks+3MarketScreener+3 What’s moving the stock today Catalyst: Q3 FY2025 results expected today Several earnings calendars show Lucyd (LUCY) slated to report Q3 2025 results before the U.S. market open on Wednesday, Nov. 12 (timing based on third‑party calendars; official company release not yet posted on the IR site at the time of publication). Watch for updates
12 November 2025
···
FedEx (FDX) Jumps as Profit Outlook Brightens; New SAF at O’Hare & Miami, Japan Transit Gains — What to Know Today (Nov. 12, 2025)

FedEx (FDX) Jumps as Profit Outlook Brightens; New SAF at O’Hare & Miami, Japan Transit Gains — What to Know Today (Nov. 12, 2025)

FDX last trade $267.72, up ~5.4% as of 12:41 UTC (Nov 12). Market move: guidance steadies peak‑season nerves FedEx shares are outperforming today after executives told investors at the Baird Global Industrial Conference that fiscal Q2 adjusted EPS will exceed last year’s $4.05, a tone that helped boost the stock into the afternoon. Several outlets echoed the message that improved profitability is expected this quarter despite a choppy macro backdrop. investors.fedex.com+1 Coverage notes the company is navigating a ~$1 billion full‑year headwind from the U.S. elimination of the “de minimis” import exemption, yet management emphasized levers to keep margins resilient.
12 November 2025
Salarius Pharmaceuticals (SLRX) Stock Jumps as $7M Offering Prices; Closing Expected November 12, 2025 Amid Decoy Therapeutics Merger

Salarius Pharmaceuticals (SLRX) Stock Jumps as $7M Offering Prices; Closing Expected November 12, 2025 Amid Decoy Therapeutics Merger

Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX) is back in the headlines today after pricing a $7 million underwritten public offering tied to its pending business combination with Decoy Therapeutics. The company said the deal is expected to close “on or about November 12, 2025,” pending customary conditions, including consummation of the Decoy transaction. PR Newswire Key takeaways What happened today (Nov. 12, 2025) Salarius confirmed the pricing of its offering for gross proceeds of ~$7 million before fees. The package includes: The company notes the registration statement on Form S‑1 (File No. 333‑284368) became effective on Nov. 10, 2025, and the
12 November 2025
··
Moderna (MRNA) today — Nov. 12, 2025: Special shareholder vote on option exchange, fresh institutional filings, and live stock action

Moderna (MRNA) today — Nov. 12, 2025: Special shareholder vote on option exchange, fresh institutional filings, and live stock action

Published: Nov. 12, 2025 (updated intraday, UTC) Key points at a glance What’s happening today (Nov. 12, 2025) 1) Shareholders vote on employee option exchange Moderna is holding a virtual special meeting at 8:00 a.m. Eastern to seek approval for a one‑time exchange of “underwater” employee stock options (Executive Committee excluded). Per the definitive proxy, at 100% participation the plan would cancel options for ~5.65M shares and regrant options for ~2.21M, reducing option overhang by ~3.44M shares. The webcast URL and meeting logistics are outlined in the SEC filing. SEC+1 Why it matters: Lower option overhang can reduce prospective dilution
12 November 2025
AMD Targets $100B Data‑Center Revenue and 35%+ Growth: Stock Lifts After Analyst Day — Nov. 12, 2025

AMD Targets $100B Data‑Center Revenue and 35%+ Growth: Stock Lifts After Analyst Day — Nov. 12, 2025

Published: Wednesday, November 12, 2025 Summary: Advanced Micro Devices, Inc. (NASDAQ: AMD) set aggressive new long‑term targets at its New York Financial Analyst Day, including a push to $100 billion in annual data‑center chip revenue within five years, a company‑wide 35%+ revenue CAGR, and non‑GAAP EPS above $20 over the next 3–5 years. Management also outlined a multi‑year AI hardware roadmap (MI400 in 2026 and MI500 in 2027) and a rack‑scale “Helios” system to challenge Nvidia’s platform lead. AMD shares moved higher in pre‑market trading on Wednesday following the event. Reuters+2Reuters+2 What AMD announced Context: Bloomberg notes AMD expects >35%
12 November 2025
···
Merck (MRK) Jumps as Oral PCSK9 Data Power Momentum; New Keytruda Diagnostic Cleared — What’s Moving the Stock Today (Nov. 12, 2025)

Merck (MRK) Jumps as Oral PCSK9 Data Power Momentum; New Keytruda Diagnostic Cleared — What’s Moving the Stock Today (Nov. 12, 2025)

Merck & Co., Inc. (NYSE: MRK) extended this week’s rally on Wednesday as investors digested fresh late‑stage results for its investigational oral PCSK9 inhibitor and an FDA clearance that supports broader precision use of Keytruda-based therapy. Below is what changed today and how it fits into Merck’s 2025 storyline. Today’s highlights at a glance Market move: why MRK is in focus today Merck shares traded higher on Wednesday after back‑to‑back catalysts in cardiometabolic and oncology. The stock’s strength follows AHA 2025 presentations showing that enlicitide—a once‑daily oral PCSK9 inhibitor—cut LDL‑C by 55.8% at 24 weeks vs. placebo in broad hypercholesterolemia
12 November 2025
·
CoreWeave (CRWV) Q3 Earnings Today: 5 Things to Watch as AI Trade Wobbles — Revenue, RPO, Power Capacity, and Big‑Tech Deals

CoreWeave Stock Today (Nov 12, 2025): CRWV Slides After Guidance Cut; Data‑Center Delay and $55.6B Backlog Take Center Stage

Updated: Nov 12, 2025, 12:30 UTC Key takeaways CoreWeave stock price now As of 12:27 UTC, CoreWeave (NASDAQ: CRWV) was trading near $88, down roughly 16% on the day. (Intraday figures are based on live market data.) Early commentary across financial media also noted a double‑digit drop in morning trade as investors digested guidance and operational updates. Nasdaq What’s moving CRWV today CoreWeave reduced its 2025 revenue outlook to $5.05–$5.15 billion, citing construction delays at a third‑party data‑center developer. Despite strong demand for its AI infrastructure, management said the timing hiccup will push some revenue into future periods. Shares fell
12 November 2025
·
ONON Stock Today (Nov 12, 2025): On Holding Hikes 2025 Outlook After Record Q3; Shares Pop Pre‑Market

ONON Stock Today (Nov 12, 2025): On Holding Hikes 2025 Outlook After Record Q3; Shares Pop Pre‑Market

Updated: November 12, 2025 On Holding AG (NYSE: ONON) delivered a muscular third‑quarter update before the bell and raised its full‑year guidance—sending the Swiss sneaker maker’s shares sharply higher in early trading. As of the pre‑market session this morning, ONON changed hands around $38, up roughly 8% from Tuesday’s close near $35.18. Reuters also flagged an early ~10% jump as the news hit, underscoring strong first reactions from investors. StockAnalysis Key takeaways What On reported On’s investor update paints a picture of broad‑based demand and expanding profitability: For readers tracking results in U.S. dollar terms, the Associated Press tallied Q3
12 November 2025
·
1 … 1,040 1,041 1,042 1,043 1,044 … 1,171

Stock Market Today

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

7 February 2026
Home Depot shares rose 0.7% to $385.15 Friday, trading between $379.10 and $386.37. Investors await a delayed U.S. jobs report Wednesday and CPI data Friday, both postponed by a brief government shutdown. Home Depot reports fourth-quarter earnings Feb. 24. The Dow closed above 50,000 for the first time.
JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

7 February 2026
JPMorgan shares rose 3.95% to $322.40 Friday, outpacing other major banks as U.S. stocks rallied and the Dow closed above 50,000 for the first time. The bank recently completed a $3 billion subordinated notes offering. Investors are watching for delayed U.S. jobs data and inflation figures next week, ahead of JPMorgan’s Feb. 23 company update.
AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Go toTop